[Advances in research of interchangeable immunization with live attenuated Japanese encephalitis vaccines and inactivated vaccines].
Zhonghua Yu Fang Yi Xue Za Zhi
; 56(5): 554-560, 2022 May 06.
Article
em Zh
| MEDLINE
| ID: mdl-35644967
ABSTRACT
Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis in Asia and the Western Pacific, which mainly invades central nervous system. Vaccination is the most important strategy to prevent JE. Currently, both live attenuated Japanese encephalitis vaccines (JE-L) and inactivated vaccines (JE-I) are in use. Due to the supply of vaccines and the personal choice of recipients, there will be a demand for interchangeable immunization of these two vaccines. However, relevant research is limited. By reviewing domestic and foreign research evidence, this article summarizes the current situation of the interchangeable use of JE-L and JE-I, and makes recommendations when the interchangeable immunization is in urgent need, so as to provide reference for practical vaccination and policymaking in China.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Encefalite Japonesa
/
Vacinas contra Encefalite Japonesa
/
Vírus da Encefalite Japonesa (Espécie)
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
Zh
Ano de publicação:
2022
Tipo de documento:
Article